Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
BLNC Stock Summary
In the News
BLNC Financial details
Company Rating
Sell
Market Cap
5.09M
Income
-878.42K
Revenue
112.5K
Book val./share
-0.2
Cash/share
0.02
Dividend
-
Dividend %
-
Employees
4
Optionable
No
Shortable
Yes
Earnings
15 Nov 2023
P/E
-5.8
Forward P/E
-
PEG
4.04
P/S
45.27
P/B
-1.17
P/C
11.75
P/FCF
-112.27
Quick Ratio
0.08
Current Ratio
0.08
Debt / Equity
-0.57
LT Debt / Equity
-0.11
-
-
EPS (TTM)
-0.04
EPS next Y
-
EPS next Q
-
EPS this Y
24.89%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
18.53%
Revenue last 5Y
106.03%
Revenue Q/Q
-
EPS Q/Q
-50%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-260%
ROE
21%
ROC
0.01%
Gross Margin
100%
Oper. Margin
-44%
Profit Margin
-781%
Payout
-
Shs Outstand
21.67M
Shs Float
8.54M
-
-
-
-
Target Price
-
52W Range
0.235-1.0
52W High
-
52W Low
-
RSI
-
Rel Volume
-
Avg Volume
-
Volume
9.52K
Perf Week
0%
Perf Month
0%
Perf Quarter
-
Perf Half Y
0%
-
-
-
-
Beta
-0.226486
-
-
Volatility
0%, 0%
Prev Close
0%
Price
0.235
Change
0%
BLNC Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 0 | 0 | 0.05 | 0.03 | 0.01 | |
Net income per share | -0.03 | -0.04 | 0.01 | -0.05 | -0.06 | |
Operating cash flow per share | -0.02 | -0.02 | -0.01 | 0 | 0 | |
Free cash flow per share | -0.02 | -0.02 | -0.01 | 0 | 0 | |
Cash per share | 0 | 0 | 0 | 0.01 | 0.02 | |
Book value per share | -0.1 | -0.13 | -0.12 | -0.15 | -0.19 | |
Tangible book value per share | -0.1 | -0.14 | -0.12 | -0.16 | -0.19 | |
Share holders equity per share | -0.1 | -0.13 | -0.12 | -0.15 | -0.19 | |
Interest debt per share | 0.08 | 0.09 | 0.11 | 0.12 | 0.12 | |
Market cap | 29.19M | 16.22M | 7.15M | 15.61M | 5.09M | |
Enterprise value | 30.66M | 18.09M | 9.27M | 17.82M | 7.32M | |
P/E ratio | -53.29 | -17.46 | 29.02 | -15.19 | -3.97 | |
Price to sales ratio | 4.38K | 4.87K | 7.15 | 24.98 | 20.58 | |
POCF ratio | -69.45 | -44.38 | -32.81 | -274.28 | 656.96 | |
PFCF ratio | -68.77 | -44.38 | -32.81 | -235.03 | 656.96 | |
P/B Ratio | -14.09 | -5.61 | -2.82 | -4.69 | -1.22 | |
PTB ratio | -14.09 | -5.61 | -2.82 | -4.69 | -1.22 | |
EV to sales | 4.6K | 5.43K | 9.27 | 28.53 | 29.56 | |
Enterprise value over EBITDA | -51.15 | -26.64 | 17.89 | 67.21 | -109.57 | |
EV to operating cash flow | -72.96 | -49.47 | -42.52 | -313.23 | 943.74 | |
EV to free cash flow | -72.24 | -49.47 | -42.52 | -268.42 | 943.74 | |
Earnings yield | -0.02 | -0.06 | 0.03 | -0.07 | -0.25 | |
Free cash flow yield | -0.01 | -0.02 | -0.03 | 0 | 0 | |
Debt to equity | -0.77 | -0.65 | -0.84 | -0.73 | -0.59 | |
Debt to assets | 5.09 | 7.89 | 1.67 | 2.41 | 5.73 | |
Net debt to EBITDA | -2.46 | -2.74 | 4.08 | 8.36 | -33.3 | |
Current ratio | 0.04 | 0.01 | 0.01 | 0.11 | 0.1 | |
Interest coverage | -4.64 | -3.34 | 2.98 | 0.92 | -0.1 | |
Income quality | 0.71 | 0.41 | -0.62 | 0.07 | -0.01 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 91.45 | 168.4 | 0.39 | 0.64 | 1.09 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.01 | 0.01 | 0 | 0 | 0 | |
Capex to operating cash flow | 0.01 | 0 | 0 | 0.17 | 0 | |
Capex to revenue | -0.63 | 0 | 0 | -0.02 | 0 | |
Capex to depreciation | -1.18 | 0 | 0 | -6.71 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0.23 | 0.36 | 0.17 | 0.4 | 0.51 | |
ROIC | 1.59 | 0.57 | -1.05 | -0.32 | 0.02 | |
Return on tangible assets | -1.76 | -3.96 | 0.19 | -1.01 | -2.99 | |
Graham Net | -0.11 | -0.15 | -0.18 | -0.19 | -0.19 | |
Working capital | -2.34M | -2.69M | -3.36M | -3.51M | -3.68M | |
Tangible asset value | -2.12M | -2.94M | -2.59M | -3.39M | -4.16M | |
Net current asset value | -2.34M | -3.14M | -3.83M | -3.98M | -4.16M | |
Invested capital | -0.77 | -0.65 | -0.84 | -0.73 | -0.59 | |
Average receivables | 16.48K | 16.48K | 0 | 99.06K | 121.56K | |
Average payables | 771.92K | 1.09M | 1.44M | 1.74M | 2M | |
Average inventory | -15.65K | -15.65K | 0 | -81.35K | -81.35K | |
Days sales outstanding | 1.8K | 0 | 0 | 115.78 | 66.36 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0.2 | 0 | 0 | 3.15 | 5.5 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.26 | 0.32 | -0.1 | 0.31 | 0.31 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
Metric | History | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 |
---|---|---|---|---|---|---|
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | -0.01 | -0.01 | -0.02 | -0.01 | 0 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | |
Book value per share | -0.18 | -0.18 | -0.19 | -0.2 | -0.2 | |
Tangible book value per share | -0.18 | -0.18 | -0.19 | -0.2 | -0.2 | |
Share holders equity per share | -0.18 | -0.18 | -0.19 | -0.2 | -0.2 | |
Interest debt per share | 0.12 | 0.12 | 0.12 | 0.12 | 0.12 | |
Market cap | 15.93M | 10.19M | 5.09M | 5.09M | 5.09M | |
Enterprise value | 18.16M | 12.37M | 7.32M | 7.33M | 7.38M | |
P/E ratio | -13.37 | -9.72 | -3.92 | -6.54 | -13.16 | |
Price to sales ratio | 236.01 | 150.92 | 113.19 | 0 | 0 | |
POCF ratio | 1.15K | 199.75 | -117.21 | -357.53 | -131.73 | |
PFCF ratio | 1.15K | 199.75 | -117.21 | -357.53 | -131.73 | |
P/B Ratio | -4.17 | -2.57 | -1.22 | -1.2 | -1.17 | |
PTB ratio | -4.17 | -2.57 | -1.22 | -1.2 | -1.17 | |
EV to sales | 268.97 | 183.3 | 162.6 | 0 | 0 | |
Enterprise value over EBITDA | -369.3 | 267.81 | -234.92 | -202.16 | -179.15 | |
EV to operating cash flow | 1.31K | 242.62 | -168.38 | -514.81 | -190.75 | |
EV to free cash flow | 1.31K | 242.62 | -168.38 | -514.81 | -190.75 | |
Earnings yield | -0.02 | -0.03 | -0.06 | -0.04 | -0.02 | |
Free cash flow yield | 0 | 0.01 | -0.01 | 0 | -0.01 | |
Debt to equity | -0.64 | -0.62 | -0.59 | -0.58 | -0.57 | |
Debt to assets | 3.18 | 4.39 | 5.73 | 6.56 | 7.29 | |
Net debt to EBITDA | -45.26 | 47.32 | -71.39 | -61.76 | -55.43 | |
Current ratio | 0.1 | 0.08 | 0.1 | 0.09 | 0.08 | |
Interest coverage | -0.2 | 0.74 | -0.35 | -0.55 | -0.72 | |
Income quality | -0.07 | -0.36 | 0.22 | 0.16 | 0.4 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 1.17 | 0.37 | 1.44 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0.02 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0.23 | 0.22 | 0.25 | 0.2 | 0.14 | |
ROIC | 0.01 | -0.05 | 0.02 | 0.04 | 0.02 | |
Return on tangible assets | -0.39 | -0.48 | -0.76 | -0.52 | -0.29 | |
Graham Net | -0.2 | -0.2 | -0.19 | -0.2 | -0.2 | |
Working capital | -3.69M | -3.73M | -3.68M | -3.77M | -3.86M | |
Tangible asset value | -3.82M | -3.97M | -4.16M | -4.25M | -4.35M | |
Net current asset value | -4.16M | -4.21M | -4.16M | -4.25M | -4.35M | |
Invested capital | -0.64 | -0.62 | -0.59 | -0.58 | -0.57 | |
Average receivables | 216.28K | 124.43K | 44.73K | 22.5K | 0 | |
Average payables | 2M | 2.05M | 2.1M | 2.15M | 2.19M | |
Average inventory | -153.5K | -81.48K | -10.98K | 0 | 0 | |
Days sales outstanding | 272.54 | 59.28 | 90 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0.33 | 1.52 | 1 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.08 | 0.07 | 0.08 | 0.05 | 0.02 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
BLNC Frequently Asked Questions
What is Balance Labs, Inc. stock symbol ?
Balance Labs, Inc. is a US stock , located in Miami beach of Fl and trading under the symbol BLNC
What is Balance Labs, Inc. stock quote today ?
Balance Labs, Inc. stock price is $0.235 today.
Is Balance Labs, Inc. stock public?
Yes, Balance Labs, Inc. is a publicly traded company.